Hay, Kevin A <br/><br/>
Chimeric Antigen Receptor (CAR) T Cells: Lessons Learned from Targeting of CD19 in B-Cell Malignancies.  [electronic resource] 

 -  Drugs  Mar 2017 
 - 237-245 p.  digital 
<br/><br/> Publication Type: Journal Article; Review 
<br/><br/><label>ISSN: </label>1179-1950 
<br/><br/><label>Standard No.: </label>10.1007/s40265-017-0690-8  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antigens, CD19--immunology<br/>Humans<br/>Immunotherapy<br/>Leukemia, Lymphocytic, Chronic, B-Cell--drug therapy<br/>Lymphoma, Non-Hodgkin--drug therapy<br/>Precursor B-Cell Lymphoblastic Leukemia-Lymphoma--drug therapy<br/>Receptors, Antigen, T-Cell--immunology<br/>T-Lymphocytes--immunology